Eli Lilly won't lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

The FDA has appointed Jeremy Walsh as its first chief artificial intelligence officer, marking a step in tech modernization at the agency. Mr. Walsh, who announced the career move in a May 2 LinkedIn ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...

The global sleep screening devices market is on a steady growth trajectory, driven by the increasing prevalence of sleep disorders and advancements in sleep health technology. Valued at USD 8,733.5 ...

GenAI, or Generative AI, has seen a surge in patenting activity with China leading the way in filing patent applications for ...

Flynn Group, one of the largest franchise operators, has entered into a new partnership with Ziosk, adding Ziosk's z Mini ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

In the healthcare technology landscape, generative AI (GenAI) is emerging as a valuable companion to longstanding predictive AI solutions. GenAI refers to AI that can assist in creating content — such ...

Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ETCompany ParticipantsChris Potochar - Vice President of Treasury ...